rs117405606
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000395.3(CSF2RB):c.1153-13T>C variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00668 in 1,602,758 control chromosomes in the GnomAD database, including 179 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0085 ( 16 hom., cov: 31)
Exomes 𝑓: 0.0065 ( 163 hom. )
Consequence
CSF2RB
NM_000395.3 splice_polypyrimidine_tract, intron
NM_000395.3 splice_polypyrimidine_tract, intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.197
Genes affected
CSF2RB (HGNC:2436): (colony stimulating factor 2 receptor subunit beta) The protein encoded by this gene is the common beta chain of the high affinity receptor for IL-3, IL-5 and CSF. Defects in this gene have been reported to be associated with protein alveolar proteinosis (PAP). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 22-36933819-T-C is Benign according to our data. Variant chr22-36933819-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 226544.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00846 (1287/152114) while in subpopulation SAS AF= 0.051 (245/4804). AF 95% confidence interval is 0.0458. There are 16 homozygotes in gnomad4. There are 672 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 16 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSF2RB | NM_000395.3 | c.1153-13T>C | splice_polypyrimidine_tract_variant, intron_variant | ENST00000403662.8 | NP_000386.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSF2RB | ENST00000403662.8 | c.1153-13T>C | splice_polypyrimidine_tract_variant, intron_variant | 5 | NM_000395.3 | ENSP00000384053 | P1 | |||
CSF2RB | ENST00000406230.5 | c.1171-13T>C | splice_polypyrimidine_tract_variant, intron_variant | 1 | ENSP00000385271 |
Frequencies
GnomAD3 genomes AF: 0.00844 AC: 1283AN: 151996Hom.: 16 Cov.: 31
GnomAD3 genomes
AF:
AC:
1283
AN:
151996
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0101 AC: 2357AN: 232220Hom.: 47 AF XY: 0.0117 AC XY: 1483AN XY: 126704
GnomAD3 exomes
AF:
AC:
2357
AN:
232220
Hom.:
AF XY:
AC XY:
1483
AN XY:
126704
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00649 AC: 9414AN: 1450644Hom.: 163 Cov.: 31 AF XY: 0.00765 AC XY: 5516AN XY: 721492
GnomAD4 exome
AF:
AC:
9414
AN:
1450644
Hom.:
Cov.:
31
AF XY:
AC XY:
5516
AN XY:
721492
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00846 AC: 1287AN: 152114Hom.: 16 Cov.: 31 AF XY: 0.00904 AC XY: 672AN XY: 74366
GnomAD4 genome
AF:
AC:
1287
AN:
152114
Hom.:
Cov.:
31
AF XY:
AC XY:
672
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
65
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 30, 2020 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | 1153-13T>C in intron 9 of CSF2RB: This variant is not expected to have clinical significance because it has been identified in 1.5% (66/4382) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs117405606). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at